0 items USD 0.00Search
Your search for "delveinsight cervical cancer global api manufacturers marketed phase iii drugs landscape 2016" gave back 83406 results.
China's demand for Cervical Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand...
Catalog:
Asia Market Information & Development Co.
March 2018
Price: USD 4,000.00
This study focuses on China’s Cervical Cancer Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has...
Catalog:
Asia Market Information & Development Co.
March 2018
Price: USD 1,800.00
Summary The global Gynecological Cancer Drugs market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define...
Catalog:
HYR
January 2022
Price: USD 1,800.00
The adult vaccines market has been forecasted to increase at a compound annual growth rate (CAGR) of around 6% over the next five years. Adults are...
Catalog:
iGATE
August 2016
Price: USD 1,490.00
Cervical cancer is a type of cancer that occurs in the cells of the cervix — the lower part of the uterus that connects to the vagina. In the context...
Catalog:
9Dimen Research
April 2020
Price: USD 2,850.00
The global Paclitaxel market size was valued at USD 121 million in 2023 and is forecast to a readjusted size of USD 205.3 million by 2030 with a CAGR...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Summary Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer...
Catalog:
HYR
August 2021
Price: USD 1,800.00
Cervical cancer is a leading cause of cancer deaths in women worldwide. In the context of China-US trade war and global economic volatility and...
Catalog:
9Dimen Research
April 2020
Price: USD 2,850.00
In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Cervical Cancer Gel...
Catalog:
9Dimen Research
April 2020
Price: USD 2,850.00
The global Paclitaxel market size was valued at US$ 115 million in 2023. With growing demand in downstream market, the Paclitaxel is forecast to a...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-...
Catalog:
MRRPB5
January 2023
Price: USD 4,000.00
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Globally Pharmaceutical markets are showing rapid growth and in coming years expected to evolve further in the field of research and development,...
Catalog:
IQ4I
May 2021
Price: USD 4,950.00
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
